Quite refreshing well-written experimental paper leaving promises of artificial organoids.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
In Situ Expansion, Differentiation and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid
April 2, 2020
A Fasco in the Making? As the Coronavirus Pandemic Takes Hold, We Are Making Decisions Without Reliable Data
March 20, 2020
Interesting input from a Stanford expert on the hottest topic on the planet at the moment.
February 20, 2020
In this Giants of Cardiothoracic Surgery interview, Joel Dunning speaks with Oscar Howard “Bud” Frazier about his career and experience with mechanical hearts.
February 20, 2020
This randomized trial evaluated depth and duration of intraoperative hypotension during noncardiac surgery, comparing a machine learning early warning system to standard care. Hypotension was defined as a MAP <65 mm Hg for one minute or more.
February 17, 2020
This video demonstrates a trainee-led open resection of four pulmonary nodules using the LEONARDO® Dual Wave 200W laser system.
December 19, 2019
A medium-size RCT on the growing research question of efficacy of peroral myotomy for achalasia, with a 17% failure to improve symptoms in the peroral endoscopic myotomy (POEM) arm, is discussed in this article.
December 17, 2019
In this Giants of Cardiothoracic Surgery interview, Varun Shetty speaks with Devi Shetty, founder and chairman of Narayana Health in Bangalore, India, about how economies of scale, low-cost micro health insurance, and technology have been critical in the effort to democratize healthcare.
December 4, 2019
Succinct commentary on the challenge of vascular access in ECMO circuits on the occasion of a manuscript on a novel design of a multi-access adaptor.
November 30, 2019
High-Throughput, Contact-Free Detection of Atrial Fibrillation From Video With Deep Learning
November 22, 2019
Puzzling subgroup from the GALILEO trial, which appears in the same issue of the periodical as an article that discredits the use of rivaroxaban as thromboprevention strategy :